¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Skin changes due to chronic exposure to nonionizing radiation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® chronic lymphocytic leukemia ÇÑ±Û ¸¸¼º¸²ÇÁ¼º ¹éÇ÷º´
¼³¸í   
  ¹éÇ÷º´(leukemia)¶õ ºñÁ¤»óÀûÀΠ¹éÇ÷±¸ ¼¼Æ÷ÀÇ Áõ½Ä¿¡ ÀÇÇØ ÀϾ´Â º´ÀûÀΠ»óŸ¦ ¸»Çϴµ¥, ÈçÈ÷ ¸»ÃÊÇ÷¾×¿¡ ¹ÌºÐÈ­¼¼Æ÷°¡ ³ªÅ¸³ª¸ç, Á¤»óÀûÀΠÀûÇ÷±¸¼¼Æ÷¿Í ¹éÇ÷±¸¼¼Æ÷, Ç÷¼ÒÆÇÀÇ ±Þ°ÝÇÑ °¨¼Ò¸¦ °¡Á®¿Í Á¤»óÀûÀΠ¼¼Æ÷¿¡ ÀÇÇØ ÇàÇØÁö´Â ¿©·¯ ±â´ÉÀÇ °¨¼Ò¸¦ ÁÖÁõ»óÀ¸·Î ÇÏ¿© º´¿ø¿¡ Ã£¾Æ¿À°Ô µÈ´Ù. µû¶ó¼­ ÀûÇ÷±¸¼¼Æ÷ÀÇ °¨¼Ò·Î ÀÎÇÑ ºóÇ÷, ¹éÇ÷±¸¼¼Æ÷ÀÇ °¨¼Ò·Î ÀÎÇÑ ¸¹Àº °¨¿°Áõ¼¼(ÈçÈ÷ °É¸®Áö ¾Ê´Â ¼¼±Õ¿¡ ÀÇÇÑ °¨¿°, Áö³ªÄ¡°Ô ÀæÀº °¨±â, Æó·Å µî), Ç÷¼ÒÆÇ¼¼Æ÷ÀÇ °¨¼Ò·Î ÀÎÇÑ ÃâÇ÷Áõ»óÀÌ ³ªÅ¸³­´Ù. ¶ÇÇÑ ÇǸ¦ »ý»êÇϴ °ñ¼ö Á¶Á÷¿¡¼­´Â ÀÌ·± ºñÁ¤»óÀûÀΠ¼¼Æ÷ÀÇ Áõ½Ä¸¸À» º¼ ¼ö ÀÖÀ¸¸ç, Á¤»óÀûÀΠ¼¼Æ÷ÀÇ Áõ½ÄÀº º¸±â Èûµé´Ù.
  
  ¸¸¼º¸²ÇÁ¼º ¹éÇ÷º´Àº ¼­¾ç¿¡¼­´Â ºñ±³Àû ¹éÇ÷º´ Áß¿¡¼­ ÈçÇÑ ÇüÀÌÁö¸¸ µ¿¾ç±Ç¿¡¼­´Â ¾ÆÁÖ µå¹® ¹éÇ÷º´ÀÇ ÇüÅÂÀÌ´Ù. ´ë°³ 60¼¼ ÀÌ»óÀÇ °í·ÉÃþ¿¡¼­ ¸¹ÀÌ »ý±â°í 30¼¼ ÀÌÇÏ¿¡¼­´Â °ÅÀǠã¾Æº¼ ¼ö°¡ ¾ø´Ù. Ç÷¾×°Ë»ç»ó¿¡¼­ ¸²ÇÁ±¸ÀÇ ¸¹Àº Áõ°¡¸¦ º¼ ¼ö°¡ ÀÖ°í, ´ë½Å¿¡ ´Ù¸¥ Ç÷¾×¼¼Æ÷µéÀº °¨¼Ò¸¦ ³ªÅ¸³½´Ù. ¹éÇ÷º´ Áß ¿¹Èİ¡ ÁÁÀº ÆíÀ̸破밳 Ä¡·á´Â Ç×¾ÏÁ¦¸¦ ÀÌ¿ëÇÑ È­Çпä¹ýÀ» ¸¹ÀÌ »ç¿ëÇϸç, Æò±Õ »ýÁ¸±â°£Àº 4~5³âÀÌ´Ù.
¿µ¹® chronic obstructive pulmonary disease ÇÑ±Û ¸¸¼ºÆó¼âÆóº´
¼³¸í   
  ¸¸¼ºÀûÀ¸·Î ±âµµÀÇ Æó¼â¸¦ °¡Á®¿À´Â º´À» À̸£´Â ¸». ´ë°³ ¸¸¼º±â°üÁö¿°, ±â°üÁö Ãµ½Ä, Æó±âÁ¾ÀÇ 3°¡Áö º´À» ¸»ÇÑ´Ù.
  
  ¸¸¼º±â°üÁö¿°À̶õ ±â°üÁöÀÇ ¸¸¼º¿°ÁõÀ» ¸»ÇÑ´Ù. ±â°üÁöÀÇ ¿°ÁõÀ¸·Î ÀÎÇØ¼­ ±â°üÁöÀÇ Á¡¸·¿¡ ºÎÁ¾ÀÌ »ý±â°í À̷ΠÀÎÇØ¼­ ±â°üÁöÀÇ ³»°æÀÌ Á¼¾ÆÁ®¼­ ±âµµÀÇ Æó¼â¸¦ °¡Á®¿Â´Ù. ´ë°³ Èí¿¬°ú ¹ÐÁ¢ÇÑ ¿¬°üÀ» °¡Áö¸ç, È£Èí°ï¶õ, ±âħ, ±×¸®°í °¡·¡(´ë°³ »öÀ̠Ǫ¸£°í Á¡µµ°¡ ³ôÀº °¡·¡)°¡ Áõ»óÀ¸·Î ³ªÅ¸³­´Ù.
  
  Æó±âÁ¾Àº ±â°üÁöÀÇ º®À» ÁöÁöÇϴ Á¶Á÷ÀÇ ÆÄ±«¿¡ ÀÇÇØ¼­ ±â°üÁö°¡ Á¦ ¸ð¾çÀ» °®ÃßÁö ¸øÇÏ°í ¹«³ÊÁö°Ô µÇ¾î ±âµµÀÇ Æó¼â°¡ ÀϾ´Â º´ÀÌ´Ù. Áï ±â°üÁö°¡ °ü ¸ð¾çÀ¸·Î ÆØÆØÇϰԠÆìÁö´Â °ÍÀ» ÁöÁöÇϴ Á¶Á÷ÀÇ ÆÄ±«¿¡ ÀÇÇØ¼­ °ü¸ð¾çÀ¸·Î ÆìÁöÁö ¸øÇØ °á±¹Àº ÆóÆ÷³»¿¡ °ø±â°¡ Â÷°í ÆóÆ÷º®ÀÌ ÆÄ¿­µÇ°í ±â°üÁö°¡ Á¼¾ÆÁö°Ô µÇ´Â º´À» ¸»ÇÑ´Ù.
  
  ±â°üÁöõ½ÄÀ̶õ ¿©·¯ °¡Áö Àڱؿ¡ ´ëÇØ¼­ ±â°üÁö°¡ °ú¹ÎÇÑ ¹ÝÀÀÀ» º¸¿©¼­ »ý±â´Â ±â°üÁöÀÇ °¡¿ªÀûÀΠÆó¼â¸¦ ÀǹÌÇÑ´Ù. Áï Á¤»óÀο¡°Ô¼­´Â ±â°üÁöÀÇ Æó¼â¸¦ º¸ÀÌÁö ¾Ê´Â Àڱؿ¡ ´ëÇØ¼­ ±â°üÁöÀÇ Æó¼â°¡ »ý±â°í ±× ÀÚ±ØÀÌ ¾øÀ» °æ¿ì¿¡´Â ±â°üÁöÀÇ Æó¼â°¡ ¾ø¾îÁö´Â º´À» ¸»ÇÑ´Ù. 
¿µ¹® chronic active hepatitis ÇÑ±Û ¸¸¼ºÈ°µ¿°£¿°
¼³¸í   
  BÇü °£¿°À̳ª ºñAÇü£­ºñBÇü °£¿°ÀÇ ¼Ó¹ßÁõÀ¸·Î ³ªÅ¸³ª´Â °£ÀÇ ¸¸¼º¿°ÁõÀÌ´Ù. °°Àº ÇüÅÂÀÇ º´ÀÌ ¼±Ãµ¼º ¶Ç´Â ÈÄõ°¨¸¶±Û·ÎºÒ¸°°áÇÌÁõÀ̳ª ¾î¶² Á¾·ùÀÇ ¾à¹° Åõ¿©¿¡ ¼ö¹ÝÇØ¼­ ³ªÅ¸³¯ ¼öµµ ÀÖ´Ù. Æ¯Â¡ÀûÀ¸·Î ¹®¸ÆºÎ¿¡ ÇüÁú¼¼Æ÷¿Í Å«Æ÷½Ä¼¼Æ÷ÀǠħÀ±, Á¶°¢±«»ç(°£¼Ò¿± ÁÖº¯ºÎ °£¼¼Æ÷ÀÇ ÆÄ±«) ¹× ¼¶À¯Áõ µîÀÇ Á¶Á÷¼Ò°ßÀ» ³ªÅ¸³½´Ù. º´ÀÇ °æ°ú´Â ¸Å¿ì ´Ù¾çÇϸç Àå±â°£ÀÇ ¹«Áõ»ó±â¸¦ º¸ÀÏ ¼öµµ ÀÖ°í ±× »çÀÌ »çÀÌ¿¡ È²´Þ, Àü½Å¼è¾à, ½Ä¿åºÎÁø ¹× ¹ß¿­ µîÀÇ Áõ»óÀÌ ³ªÅ¸³ª´Â ¼ö°¡ ÀÖÀ¸¸ç, ¶Ç ¹«¿ù°æÁõ, °üÀý¿°, ÇǺιßÁø, Ç÷°ü¿°, °©»ó»ù¿°, ÄáÆÏ»ç±¸Ã¼¿°, ±Ë¾ç¼º´ëÀå¿°, ½¦±×·»ÁõÈıº µî °£ ÀÌ¿ÜÀÇ Áõ»óÀÌ ³ªÅ¸³ª´Â ¼öµµ ÀÖ°í, °£°æÈ­Áõ°ú °£±â´É»ó½Ç·Î ÁøÇàµÇ´Â ¼öµµ ÀÖ´Ù. ÀÚ°¡¸é¿ª¸ÞÄ¿´ÏÁòÀÌ °ü¿©µÇ´Â °ÍÀ¸·Î ÃßÃøµÇ°í ÀÖ´Ù.
¿µ¹® basal layer of skin ÇÑ±Û ±âÀúÃþ
¼³¸í   
  Ç¥ÇÇÀÇ °¡À堾Ʒ¡ ºÎºÐÀ̸砼¼Æ÷ÀÇ ¸ð¾çÀÌ ºñ±³Àû Á÷»ç°¢Çü¿¡ °¡±õ°í ÀÏÁ¤ÇÑ ¹è¿­À» ÇÑ´Ù.
¿µ¹® radiation ÇÑ±Û ¹æ»ç¼±
¼³¸í   
  ºûÀÇ ÀüÀÚÀÚ±âÆÄ³ª È¤Àº ÀÔÀÚÆÄ(¥á, ¥â, ¥ã¼±)¸¦ ¸»Çϴµ¥, ¾î¶² ±Ù¿ø¹°Áú¿¡¼­ »ý°Ü ¹æÃâµÈ´Ù. À̿½ÖÀ» »ý¼ºÇϴ °í¿¡³ÊÁö ¹æ»ç¼±(X-¼±°ú °¨¸¶¼±)À» ¸»ÇÑ´Ù. ¹æ»ç¼±Çϸé, ÁַΠÀü¸®¹æ»ç¼±À» ÀǹÌÇÑ´Ù. ÀÌ·± ¹æ»ç¼±À» ÀÌ¿ëÇÏ¿©, °¡À報⺻ÀûÀΠ¹æ»ç¼±ÇÐÀû °Ë»ç¸¦ ÇÒ ¼ö ÀÖÀ¸¸ç, À̿ܠġ·á¿¡µµ ÀÌ¿ëÇϰí ÀÖ´Ù. °¢ ¹æ»ç¼±ÀÇ Á¾·ù¿¡ µû¶ó Á¶±Ý¾¿ ÀÎü¿¡ ¹ÌÄ¡´Â ¿µÇâÀÌ ´Ù¸£¸ç, À̸¦ ÀÌ¿ëÇÏ¿© °¢±â ´Ù¸£°Ô Áø´Ü ¹× Ä¡·á¿¡ ÀÌ¿ëÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nonionizing radiation
    ºñÀÌ¿ÂÈ­¹æ»ç¼±
  • chronic exposure
    ¸¸¼º³ëÃâ
  • permissible radiation exposure level
    Çã¿ë¹æ»ç¼±ÇÇÆø¼±·®
  • radiation exposure
    ¹æ»ç¼±³ëÃâ
  • accidental exposure
    »ç°íÇÇÆø, »ç°í³ëÃâ
  • acute exposure
    ±Þ¼º³ëÃâ
  • cumulative glycemic exposure
    ´©Àû°íÇ÷´ç³ëÃâ
  • double exposure technique
    Áߺ¹X¼±ÃÔ¿µ(¼ú)
  • exposure
    1. ³ëÃâ 2. Á¶»ç 3. Á¶»ç¼±·® 4. Æø·Î 5. ÇÇÆø
  • exposure dose
    Æø·Î¼±·®
  • exposure keratitis
    ³ëÃâ°¢¸·¿°
  • exposure rate
    ³ëÃâ·ü, ÇÇÆø·ü
  • exposure rate constant
    ÇÇÆø·ü»ó¼ö
  • exposure ratio
    ³ëÃâºñÀ²
  • exposure time
    ³ëÃâ½Ã°£, Æø·Î½Ã°£
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • radiation exposure
    ¹æ»ç¼±³ëÃâ
  • anemia of chronic disease
    ¸¸¼ºº´ºóÇ÷
  • chronic
    ¸¸¼º-
  • chronic renal failure
    ¸¸¼ºÄáÆÏ±â´É»ó½Ç, ¸¸¼º½ÅºÎÀü(Áõ)
  • chronic atrophic gastritis
    ¸¸¼ºÀ§ÃàÀ§¿°
  • chronic relapsing pancreatitis
    ¸¸¼ºÀç¹ßÀÌÀÚ¿°, ¸¸¼ºÀç¹ßÃéÀå¿°
  • exposure
    ³ëÃâ
  • occupational exposure
    Á÷¾÷³ëÃâ
  • public exposure
    °øÁßÇÇÆø, °øÁß³ëÃâ
  • sun exposure
    Àϱ¤³ëÃâ
  • exposure time
    ³ëÃâ½Ã°£, Æø·Î½Ã°£
  • skin care
    ÇǺΰü¸®
  • skin dose
    ÇǺμ±·®
  • skin flare
    ÇǺιßÀû
  • skin fold
    ÇǺÎÁÖ¸§
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nonionizing radiation
    ºñÀ̿¹æ»ç¼±
  • chronic exposure
    ¸¸¼ºÇÇÆø, ¸¸¼º³ëÃâ
  • radiation exposure
    ¹æ»ç¼±³ëÃâ
  • permissible radiation exposure level
    Çã¿ë¹æ»ç¼±ÇÇÆø¼±·®
  • target skin distance radiation
    Ç¥ÀûÇǺΰŸ®¹æ»ç¼±
  • chronic
    ¸¸¼º-
  • chronic active photosensitive dermatitis
    ¸¸¼ºÈ°¼º±¤¼±°ú¹ÎÇǺο°
  • chronic active hepatitis
    ¸¸¼ºÈ°µ¿°£¿°
  • chronic fatigue syndrome
    ¸¸¼ºÇÇ·ÎÁõÈıº
  • chronic granulomatous disease
    ¸¸¼ºÀ°¾ÆÁ¾º´
  • chronic hypertrophic rhinitis
    ¸¸¼ººñÈÄÄÚ¿°, ¸¸¼ººñÈĺñ¿°
  • chronic myeloproliferative disorder
    ¸¸¼º°ñ¼öÁõ½ÄÁúȯ
  • chronic obstructive pulmonary disease
    ¸¸¼ºÆó¼âÆóÁúȯ, ¸¸¼ºÆó¼âÆóº´
  • chronic pain syndrome
    ¸¸¼ºÅëÁõÁõÈıº
  • chronic persistent hepatitis
    ¸¸¼ºÁö¼Ó°£¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • postmortem changes
    »çÈĺ¯È­(ÞÝý­Ü¨ûù)
  • premenstrual affective changes
    ¿ù°æÀü Á¤µ¿º¯È­(êÅÌèîñ ïñÔÑܨûù)£®
  • accidental exposure
    »ç°í½ÃÇÇÆø, °ú½ÇÇÇÆø
  • acute exposure
    ±Þ¼ºÇÇÆø
  • prolonged exposure
    Àå±â³ëÃâ.
  • public exposure
    °øÁßÇÇÆø
  • COPD=> chronic obstructive pulmonary disease
    ¸¸¼ºÆó»ö(¼â)¼º ÆóÁúȯ(Ø·àõøÍßáàõøËòðü´)
  • Chronic fatigue syndrome
    ¸¸¼ºÇÇ·Î ÁõÈıº
  • Hailey-Hailey disease = familial benign chronic pemphigus
    ÇìÀϸ®-ÇìÀϸ®º´
  • hepatitis,chronic active
    ¸¸¼ºÈ°µ¿¼º(Ø·àõüÀÔÑàõ)
  • hepatitis,chronic persistent
    ¸¸¼ºÁö¼Ó¼º(Ø·àõò¥áÙàõ)
  • pharyngitis, chronic
    ¸¸¼ºÀεο°
  • pharyngitis, chronic hypertrophic
    ¸¸¼ººñÈÄ(¼º) Àεο°
  • pharyngitis, chronic lateral
    ¸¸¼º¿ÜÃø(¼º) Àεο°
  • ESR=£¾electric skin resistance
    ÇǺÎ(ù«Ý±)Àü±â(ï³Ñ¨)ÀúÇ×(î½ù÷).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nonionizing radiation
    ºñÀ̿¼º ¹æ»ç¼±
  • chronic actinic changes
    ¸¸¼º(´ÜÆÄ)±¤¼±¼º º¯È­(Ø·àõÓ­÷îÎÃàÊàõܨûù).
  • jaundice due to biliary stasis
    ´ãÁó¿ïü¼º Ȳ´Þ(ÓÅñðê¦ôòàõüÜÓ¸).
  • chronic exposure
    ¸¸¼ºÇÇÆø
  • postmortem changes
    »çÈĺ¯È­(ÞÝý­Ü¨ûù)
  • premenstrual affective changes
    ¿ù°æÀü Á¤µ¿º¯È­(êÅÌèîñ ïñÔÑܨûù)£®
  • nuclear radiation exposure
  • permissible radiation exposure level
    Çã¿ë¹æ»ç¼±ÇÇÆø¼±·®
  • chronic radiation dermatitis
    ¸¸¼º ¹æ»ç¼± ÇǺο°
  • target skin distance radiation
    Ç¥ÀûÇǺΰŸ®¹æ»ç¼±
  • accidental exposure
    »ç°í½ÃÇÇÆø, °ú½ÇÇÇÆø
  • acute exposure
    ±Þ¼ºÇÇÆø
  • chemical exposure
    È­ÇÐÀû ³ëÃâ<Æø·Î
  • continuous exposure
    ¿¬¼ÓÇÇÆø
  • double exposure technique
    Áߺ¹ X¼±ÃÔ¿µ¼ú
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Polar radiation
    ±ØºÎê»ì
    [¿¾ ¿ë¾î] ±Ø¹æ»ç
  • Radiation of corpus callosum
    ³úµéº¸ºÎê»ì
    [¿¾ ¿ë¾î] ³ú·®¹æ»ç
  • Radiation (Cosmic ray)
    ¹æ»ç¼±(¿ìÁÖ¼±)
    [¿¾ ¿ë¾î] ¹æ»ç¼±
  • Optic radiation
    ½Ã°¢·ÎºÎê»ì
    [¿¾ ¿ë¾î] ½Ã¹æ»ç
  • Auditory radiation
    û°¢·ÎºÎê»ì
    [¿¾ ¿ë¾î] û¹æ»ç
  • Skin of glans
    ±ÍµÎÇǺÎ
    [¿¾ ¿ë¾î] ±ÍµÎÇǺÎ
  • Skin retinacula
    ÇǺÎÁöÁö¶ì
    [¿¾ ¿ë¾î] ÇǺÎÁö´ë
  • Skin of penis
    À½°æÇǺÎ
    [¿¾ ¿ë¾î] À½°æÇǺÎ
  • Skin of scrotum
    À½³¶ÇǺÎ
    [¿¾ ¿ë¾î] À½³¶ÇǺÎ
  • Skin
    ÇǺÎ
    [¿¾ ¿ë¾î] ÇǺÎ
  • Skin
    ÇǺΠ[»ì°¯]
    [¿¾ ¿ë¾î] ÇǺÎ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chronic malaria
    ¸¸¼º¸»¶ó¸®¾Æ
  • skin snip biopsy
    ÇǺÎÁ¶°¢»ý°Ë
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chronic toxicity test
    ¸¸¼º µ¶¼º½ÃÇè(Ø·àõÔ¸àõãËúÐ)
  • exposure dose
    ³ëÃâ·®(ÖÚõóÕá)
  • gaseous exposure method
    °³½º ³ëÃâ¹ý(ÖÚõóÛö)
  • internal radiation
    ³»ºÎ¹æ»ç(ҮݻۯÞÒ)
  • ionizing radiation
    "Àü¸®¹æ»ç¼±(ï³×îÛ¯ÞÒàÊ), ÀÌ¿ÂÈ­(ûù) ¹æ»ç¼±(Û¯ÞÒàÊ)"
  • radiation
    "¹æ»ç(Û¯ÞÒ)[¼±,àÊ]"
  • radiation absorbed dose
    ¹æ»ç¼± Èí¼ö·®(Û¯ÞÒàÊýåâ¥Õá)
  • radiation biochemistry
    ¹æ»ç¼± »ýÈ­ÇÐ(Û¯ÞÒàÊßæûùùÊ)
  • radiation chimera
    ¹æ»ç¼±(Û¯ÞÒàÊ) Ű¸Þ¶ó
  • radiation curing
    ¹æ»ç¼± óġ(ô¥öÇ)[ÂÉÀÓ]
  • radiation dose
    ¹æ»ç¼±·®(Û¯ÞÒàÊÕá)
  • radiation sickness
    ¹æ»ç¼±º´(Û¯ÞÒàÊÜ»)
  • radioactive radiation
    ¹æ»ç¼º Á¶»ç(º¹»ç)(Û¯ÞÒàõðÎÞÒ(ÜßÞÒ))
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chronic
    ¸¸¼ºÀÇ
  • nonionizing
    ºñÀü¸®
  • double exposure technique
    Áߺ¹X¼±ÃÔ¿µ¼ú
  • exposure
    ³ëÃâ, Æø·Î, Á¶»ç
  • exposure time
    ³ëÃâ½Ã°£, Á¶ ½Ã°£
  • onion skin
    ¾çÆÄ²®Áú
  • onion-skin type
    ¾çÆÄ²®Áú¸ð¾ç
  • skin
    ÇǺÎ
  • skin cancer
    ÇǺξÏ
  • skin dose
    ÇǺμ±·®
  • skin folds
    ÇǺÎÁÖ¸§
  • skin graft
    ÇǺÎÀ̽Ä(Æí)
  • skin preparation
    ÇǺÎÁغñ
  • skin suture
    ÇǺκÀÇÕ(¼ú)
  • skin test
    ÇǺÎ(¹ÝÀÀ)°Ë»ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
POEMS polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes [syndrome]
CP candle power; capillary pressure; cardiac pacing; cardiac performance; cardiopulmonary; caudate puta...
CRD carbohydrate-recognition domain; chronic renal disease; chronic respiratory disease; child restraint...
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
ALARA as low as reasonably achievable [radiation exposure]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DUE DNA unwinding element
DUE Drug usage evaluation
14C Changes in
ACH air changes per hour
EPC erosive prepyloric changes
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • L57
    Skin changes due to chronic exposure to nonionizing radiation
    ºñÀü¸®¼º ¹æ»ç¼±¿¡ ¸¸¼º ³ëÃâ¿¡ ÀÇÇÑ ÇǺΠº¯È­
  • L57.9
    Skin changes due to chronic exposure to nonionizing radiation, unspecified
    »ó¼¼ºÒ¸íÀÇ ºñÀü¸®¼º ¹æ»ç¼±¿¡ ¸¸¼º ³ëÃâ¿¡ ÀÇÇÑ ÇǺκ¯È­
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • nonionizing radiation
    ºñÀÌ¿ÂÈ­ ¹æ»ç¼±
  • jaundice due to biliary stasis
    ´ãÁó ¿ïü¼º Ȳ´Þ
  • permissible radiation exposure level
    »ç¼± ³ëÃâ Çã¿ë·®
  • radiation exposure
    ¹æ»ç¼± ³ëÃâ, ¹æ»ç¼± Á¶»ç
  • chronic exposure
    ¸¸¼º ³ëÃâ
  • chronic radiation dermatitis
    ¸¸¼º ¹æ»ç¼± ÇǺο°
  • acute exposure
    ±Þ¼º ÇÇÆø
    ¹æ»ç¼± °Ç°­°ü¸®Çлó »ç¿ëµÇ´Â ¿ë¾îÀÌ°í ¹æ»ç¼± »ç°í µî, ºñ±³Àû ªÀº ½Ã°£¿¡ °íü°¡ ÇÇÆøÇÏ´Â °ÍÀ» ¸»ÇÑ´Ù. Á÷¾÷ÀûÀ¸·Î ¾Æ¹«·¡µµ ÇÇÇÒ ¼ö ¾ø´Â ÇÇÆøÀ̳ª ½ºÆ®·ÐƬÀÇ »À¿¡ ´ëÇÑ Ä§Âø µî Àå¹Ý°¨±âÀÇ ¹æ»ç¼± µ¿À§¿ø¼Ò°¡ ¸ö ¾È¿¡ µé¾î°£ °æ¿ìÀÇ ÇÇÆøÀ» ¸¸¼º ÇÇÆøÀ̶ó°í ¸»Çϴµ¥ ´ëÇØ¼­ À̰°ÀÌ ¸»ÇÑ´Ù.
  • chemical exposure
    È­ÇÐÀû ³ëÃâ
  • double exposure technique
    Áߺ¹ X¼± ÃÔ¿µ¼ú
  • ensitization 1. administration of antigen to induce a primary immune response; priming; immunization. 2. exposure to allergen that results in the development of hypersensitivity. 3. the coating of erythrocytes with antibody so that they are subject to lys
    ³»¹ø
    ƯÈ÷ ¾È°Ë ¿¬ÀÇ.
  • exposure dose
    Á¶»ç·®
  • exposure threshold
    ³ëÃâ ÇѰèÄ¡
  • exposure time per session
    ´ÜÀ§´ç ³ëÃ⠽ð£
  • long-term exposure
    Àå±â ³ëÃâ
  • maximum permissible exposure
    ÃÖ´ë Çã¿ë ³ëÃâ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
radiation, nonionizing Electromagnetic radiation which does not produce ions in matter through which it passes. Its wavelengths are generally greater than those of far ultraviolet radiation and range through the longest radio waves.
(12 Dec 1998)
body temperature changes Any deviation from normal body temperature of the human body, about 98.6 degrees f. Or 37 degrees c. When taken orally.
(12 Dec 1998)
postmortem changes Changes that occur in bodies after death.
(12 Dec 1998)
trophic changes Abnormalities of the skin, hair, nails, subcutaneous tissues and bone, caused by peripheral nerve lesions.
Synonym: neuritic atrophy, neurogenic atrophy, neurotrophic atrophy, trophic changes.
(05 Mar 2000)
due date The estimated calendar date when a baby will be born, the date the baby is due to be born. It is also called the estimated date of confinement (EDC).
(12 Dec 1998)
dystonia, focal, due to blepharospasm The second most common focal dystonia, the involuntary, forcible closure of the eyelids. The first symptoms may be uncontrollable blinking. Only one eye may be affected initially, but eventually both eyes are usually involved. The spasms may leave the eyelids completely closed causing functional blindness even though the eyes and vision are normal.
(12 Dec 1998)
dystonia, focal, due to torticollis Spasmodic torticollis, or torticollis, is the most common of the focal dystonias. In torticollis, the muscles in the neck that control the position of the head are affected, causing the head to twist and turn to one side. In addition, the head may be pulled forward or backward.
(12 Dec 1998)
thrombotic disease due to protein c deficiency Protein C is a protein in plasma that enters into the cascade of biochemical events leading to the formation of a clot. Deficiency of protein c results in thrombotic (clotting) disease and excess platelets with recurrent thrombophlebitis (inflammation of the vein that occurs when a clot forms). The clot can break loose and travel through the blood stream (thromboembolism) to the lungs causing a pulmonary embolism, brain causing a stroke (cerebrovascular accident), heart causing an early heart attack, skin causing what in the newborn is called neonatal purpura fulminans, the adrenal gland causing haemorrhage with abdominal pain, abnormally low blood pressure (hypotension), and salt loss. Protein c deficiency is due to possession of one gene (heterozygosity) in chromosome band 2q13-14. The possession of two such genes (homozygosity) is usually lethal.
(12 Dec 1998)
maternal exposure Exposure of the female parent, human or animal, to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals that may affect offspring. It includes pre-conception maternal exposure.
(12 Dec 1998)
maximum permissible exposure level The highest level of exposure to a substance, usually noxious, in the environment or during diagnostic and therapeutic procedures, that a body can tolerate without injury.
(12 Dec 1998)
paternal exposure Exposure of the male parent, human or animal, to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals that may affect offspring.
(12 Dec 1998)
permissible exposure limit An occupational health standard to safeguard workers against dangerous contaminants in the workplace.
(05 Mar 2000)
prenatal exposure delayed effects Delayed effects on offspring of maternal or foetal prenatal exposure to drugs, radiation and other physical agents, manipulation, nutrition, stress, etc.
(12 Dec 1998)
short-term exposure limit The maximum concentration of a chemical to which workers may be exposed continuously for up to 15 minutes without danger to health or work efficiency and safety.
(05 Mar 2000)
dental pulp exposure The result of pathological changes in the hard tissue of a tooth caused by carious lesions, mechanical factors, or trauma, which render the pulp susceptible to bacterial invasion from the external environment.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chronic
    ¸¸¼ºÀûÀÎ
  • chronic
    Àå±â°£¿¡ °ÉÄ£;¿À·¡ °Ô¼ÓÇÏ´Â;¸¸¼ºÀûÀÎ;¹ö¸©ÀÌ µÈ;»ó½ÀÀûÀÎ;(º´ÀÌ)¸¸¼ºÀÇ;°íÁúÀÇ;½ÈÀº;½ÉÇÑ;¸¸¼ºº´ ȯÀÚ;Áöº´À» °¡Áø »ç¶÷;ically ¸¸¼ºÀûÀ¸·Î;ÁúÁú ½Ã°£À» ²ø¾î
  • due
    Á¤´çÇÑ,-¿¡ ÀÇÇÑ,Á¤È®È÷
  • due
    ÀÀ´çÄ¡·¯¾ßÇÒ;ÀÀ´ç;¿¡ µ¹¿©¾ßÇÒ;ÇÒ ¿¹Á¤ÀÎ;´ç¿¬ÇÒ;Á¤½ÄÀ¸·Î;¶§°¡ ¿À¸é;¸¶¶¥È÷;¼¼±Ý
  • due bill
    Â÷¿ë Áõ¼­
  • due date
    ¾îÀ½ÀÇ ¸¸±âÀÏ
  • due process
    (¹ý)Á¤´çÇÑ ¹ýÀÇ ÀýÂ÷(¹Ì±¹ Çå¹ý Á¦ 5Á¶,Á¦ 14Á¶)
  • postage due
    ¿ìÆí ¿ä±Ý ºÎÁ·
  • exposure
    ³ëÃâ
  • double exposure
    (»ç)ÀÌÁß ³ëÃâ
  • exposure
    ¹ö·ÁµÒ;(Áý,¹æÀÇ)Çâ;³ëÃâ;Æø·Î;Àû¹ß;(¾î¸°¾ÖÀÇ)À¯±â
  • exposure index
    ³ë±¤Áö¼ö
  • exposure meter
    ³ëÃâ°è
  • indecent exposure
    (¹ý)°ø°³Àû ¿Ü¼³ÁË
  • time exposure
    ŸÀÓ ³ëÃâ(ÀÇ »çÁø)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á